Scientific guidelines (human and veterinary)https://www.ema.europa.eu/en/homepageScientific guidelines (human and veterinary)en-gbCopyright: (C) European Medicines AgencyFri, 10 May 2024 01:12:07 +0200Fri, 03 May 2024 09:50:00 +0200Reflection paper on use of real-world data in non-interventional studies to generate real-world evidencehttps://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-use-real-world-data-non-interventional-studies-generate-real-world-evidence_en.pdfReflection paper on use of real-world data in non-interventional studies to generate real-world evidencehttps://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-use-real-world-data-non-interventional-studies-generate-real-world-evidence_en.pdfFri, 03 May 2024 09:50:00 +0200Scientific guidelines (human and veterinary)Addendum to EMA/CHMP/CVMP/QWP/17760/2009 Rev 3: Defining the Scope of an NIRS Procedurehttps://www.ema.europa.eu/en/documents/scientific-guideline/addendum-ema-chmp-cvmp-qwp-17760-2009-rev-3-defining-scope-nirs-procedure_en.pdf-0Addendum to EMA/CHMP/CVMP/QWP/17760/2009 Rev 3: Defining the Scope of an NIRS Procedurehttps://www.ema.europa.eu/en/documents/scientific-guideline/addendum-ema-chmp-cvmp-qwp-17760-2009-rev-3-defining-scope-nirs-procedure_en.pdf-0Thu, 02 May 2024 14:50:47 +0200Scientific guidelines (human and veterinary)Guideline on stability testing for applications for variations to a marketing authorisation for veterinary medicinal productshttps://www.ema.europa.eu/en/documents/scientific-guideline/guideline-stability-testing-applications-variations-marketing-authorisation-veterinary-medicinal-products_en.pdfGuideline on stability testing for applications for variations to a marketing authorisation for veterinary medicinal productshttps://www.ema.europa.eu/en/documents/scientific-guideline/guideline-stability-testing-applications-variations-marketing-authorisation-veterinary-medicinal-products_en.pdfThu, 02 May 2024 09:25:30 +0200Scientific guidelines (human and veterinary)Concept paper on revision of the Guideline on Risk Assessment of Medicinal Products on Human Reproduction and Lactation: from Data to Labellinghttps://www.ema.europa.eu/en/documents/scientific-guideline/concept-paper-revision-guideline-risk-assessment-medicinal-products-human-reproduction-lactation-data-labelling_en.pdfConcept paper on revision of the Guideline on Risk Assessment of Medicinal Products on Human Reproduction and Lactation: from Data to Labellinghttps://www.ema.europa.eu/en/documents/scientific-guideline/concept-paper-revision-guideline-risk-assessment-medicinal-products-human-reproduction-lactation-data-labelling_en.pdfThu, 02 May 2024 09:10:57 +0200Scientific guidelines (human and veterinary)Concept paper for the development of a guideline on the safety of nanoparticles – in the context of the establishment of maximum residue limits and veterinary marketing authorisationshttps://www.ema.europa.eu/en/documents/scientific-guideline/concept-paper-development-guideline-safety-nanoparticles-context-establishment-maximum-residue-limits-veterinary-marketing-authorisations_en.pdfConcept paper for the development of a guideline on the safety of nanoparticles – in the context of the establishment of maximum residue limits and veterinary marketing authorisationshttps://www.ema.europa.eu/en/documents/scientific-guideline/concept-paper-development-guideline-safety-nanoparticles-context-establishment-maximum-residue-limits-veterinary-marketing-authorisations_en.pdfFri, 26 Apr 2024 14:30:00 +0200Scientific guidelines (human and veterinary)Draft guideline on good agricultural and collection practice (GACP) for starting materials of herbal origin - Revision 1https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-good-agricultural-collection-practice-gacp-starting-materials-herbal-origin-revision-1_en.pdfDraft guideline on good agricultural and collection practice (GACP) for starting materials of herbal origin - Revision 1https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-good-agricultural-collection-practice-gacp-starting-materials-herbal-origin-revision-1_en.pdfThu, 18 Apr 2024 11:31:51 +0200Scientific guidelines (human and veterinary)Draft guideline on the pharmaceutical quality of inhalation and nasal medicinal productshttps://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-pharmaceutical-quality-inhalation-nasal-medicinal-products_en.pdfDraft guideline on the pharmaceutical quality of inhalation and nasal medicinal productshttps://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-pharmaceutical-quality-inhalation-nasal-medicinal-products_en.pdfFri, 12 Apr 2024 10:03:09 +0200Scientific guidelines (human and veterinary)Draft guideline on the requirements for demonstrating therapeutic equivalence between orally inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD)https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-requirements-demonstrating-therapeutic-equivalence-between-orally-inhaled-products-oip-asthma-chronic-obstructive-pulmonary-disease-copd_en.pdfDraft guideline on the requirements for demonstrating therapeutic equivalence between orally inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD)https://www.ema.europa.eu/en/documents/scientific-guideline/draft-guideline-requirements-demonstrating-therapeutic-equivalence-between-orally-inhaled-products-oip-asthma-chronic-obstructive-pulmonary-disease-copd_en.pdfFri, 12 Apr 2024 09:12:50 +0200Scientific guidelines (human and veterinary)